BEONE MEDICINES LTD-ADR (ONC) Stock Earnings & Estimates
USA - NASDAQ:ONC - US07725L1026 - ADR
316.42 USD
-1.6 (-0.5%)
311 USD
-5.42 (-1.71%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.566B 26.06% | 17.423B 82.13% | 27.214B 56.19% | 37.381B 37.36% | 45.598B 21.98% | 51.166B 12.21% | 57.597B 12.57% | 63.784B 10.74% | 71.095B 11.46% | 75.889B 6.74% | 78.968B 4.06% | |
| EBITDA YoY % growth | N/A -38.91% | N/A 26.94% | N/A 56.75% | 1.743B 150.24% | 5.51B 216.12% | 8.93B 62.07% | 19.52B 118.59% | 26.179B 34.11% | 31.491B 20.29% | 36.614B 16.27% | 30.173B -17.59% | |
| EBIT YoY % growth | -12.026B -27.00% | -8.751B 27.23% | -4.242B 51.53% | 449.4M 110.59% | 4.601B 923.81% | 6.557B 42.51% | 13.585B 107.18% | 16.587B 22.10% | 21.191B 27.76% | 23.778B 12.21% | 25.599B 7.66% | |
| Operating Margin | -125.71% | -50.22% | -15.59% | 1.20% | 10.09% | 12.82% | 23.59% | 26.00% | 29.81% | 31.33% | 32.42% | |
| EPS YoY % growth | -143.82 45.69% | -65.53 54.44% | -47.51 27.49% | 11.04 123.23% | 38.84 251.89% | 64.95 67.24% | 1,182.03 1,719.98% | 1,329.05 12.44% | 1,765.23 32.82% | 1,628.29 -7.76% | 2,245.15 37.88% |
All data in CNY
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | 8.56 193.95% | 4.14 -98.71% |
| Revenue Q2Q % growth | 10.244B 42.75% | 10.634B 34.47% |
| EBITDA Q2Q % growth | 1.231B | 1.064B |
| EBIT Q2Q % growth | 924.71M 208.00% | 706.24M 220.67% |
All data in CNY
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 5.51 104.68% | 0.43 | 5.08 | 1,187.13% |
| Q1 2025 Q2Q % growth | 124.55 150.90% | -4.14 | 128.69 | 3,109.85% |
| Q4 2024 Q2Q % growth | 320.01 1,260.99% | 16.84 | 303.17 | 1,800.57% |
| Q3 2024 Q2Q % growth | -9.11 -159.34% | -7.42 | -1.69 | -22.81% |
| Q2 2024 Q2Q % growth | -117.64 -323.98% | -12.98 | -104.66 | -805.99% |
| Q1 2024 Q2Q % growth | -244.68 -856.85% | -22.26 | -222.42 | -999.20% |
| Q4 2023 Q2Q % growth | -27.56 18.03% | -11.70 | -15.86 | -135.57% |
| Q3 2023 Q2Q % growth | 15.36 138.68% | -26.83 | 42.18 | 157.25% |
| Q2 2023 Q2Q % growth | -27.75 30.85% | -25.68 | -2.06 | -8.03% |
| Q1 2023 Q2Q % growth | -25.57 15.81% | -25.26 | -0.32 | -1.25% |
| Q4 2022 Q2Q % growth | -33.62 25.20% | -13.41 | -20.21 | -150.68% |
| Q3 2022 Q2Q % growth | -39.70 | -39.81 | 0.11 | 0.28% |
| Q2 2022 Q2Q % growth | -40.12 | -31.39 | -8.73 | -27.81% |
| Q1 2022 Q2Q % growth | -30.37 | -26.97 | -3.41 | -12.63% |
| Q4 2021 Q2Q % growth | -44.96 | -35.96 | -9.00 | -25.02% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 9.47B 40.76% | 8.91B | 560.399M | 6.29% |
| Q1 2025 Q2Q % growth | 8.074B 50.65% | 8.176B | -102.423M | -1.25% |
| Q4 2024 Q2Q % growth | 7.908B 73.88% | 7.496B | 412.084M | 5.50% |
| Q3 2024 Q2Q % growth | 7.176B 27.60% | 7.158B | 18.363M | 0.26% |
| Q2 2024 Q2Q % growth | 6.728B 60.77% | 5.255B | 1.473B | 28.03% |
| Q1 2024 Q2Q % growth | 5.359B 74.78% | 4.557B | 802.338M | 17.61% |
| Q4 2023 Q2Q % growth | 4.548B 68.60% | 4.07B | 478.108M | 11.75% |
| Q3 2023 Q2Q % growth | 5.624B 111.55% | 4.108B | 1.516B | 36.90% |
| Q2 2023 Q2Q % growth | 4.185B 84.97% | 3.256B | 928.839M | 28.53% |
| Q1 2023 Q2Q % growth | 3.066B 57.42% | 2.897B | 169.389M | 5.85% |
| Q4 2022 Q2Q % growth | 2.698B 98.00% | 2.44B | 257.639M | 10.56% |
| Q3 2022 Q2Q % growth | 2.659B 99.05% | 2.406B | 252.516M | 10.50% |
| Q2 2022 Q2Q % growth | 2.262B 135.16% | 2.048B | 214.396M | 10.47% |
| Q1 2022 Q2Q % growth | 1.948B -50.42% | 1.838B | 109.858M | 5.98% |
| Q4 2021 Q2Q % growth | 1.362B 105.94% | 1.413B | -50.562M | -3.58% |
| Q3 2021 Q2Q % growth | 1.336B -8.44% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 8.23% | 1258.99% | 8.23% | 154.45% |
| Revenue | 0% | 9.7% | -1.58% | 1.23% |